Compliance method
AssigneeNicoventures Trading Limited
InventorsMichael McEwan, George Grant Hardie, Oscar Camacho
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods incorporating the use of a biomarker (CEVal) for assessing compliance with a smoking cessation program, for example, a smoking cessation program which involves subjects switching from conventional cigarettes to a hybrid device, an e-cigarette and/or a tobacco heating product, a smoking cessation program involving the use of nicotine replacement therapy, a smoking cessation program involving lifestyle choices or therapy, or a combination thereof.
Claims15
1-15. (canceled)
A method of assessing compliance with a smoking cessation program, said method comprising:
- (a) providing one or more blood samples from a subject;
- (b) measuring the level of N-(2-cyanoethyl) valine (CEVal) from the one or more blood samples of the subject in a biological assay;
- (c) comparing the level obtained in step (b) with reference levels of CEVal for the smoking cessation program;
- and
- (d) stratifying the subject according to compliance with the smoking cessation program based on the comparison in step (c).
Dependencies are inferred from the claim text.